Biotech Stocks

Sarepta (SRPT) Stock Still Worth Over $200, Says Top Analyst

On Monday, when the FDA came out against Sarepta Therapeutics’ (SRPT) Duchenne muscular dystrophy drug Vyondys 53, investors knew the shockwaves would immediately …

3 Healthcare Stocks to Fight Off the Market Flu

2019 has been a good year for the stock market. Year-to-date, both the S&P 500 and the Nasdaq are up 15% and 19%, …

Another Day, Another Buy Rating for Amarin (AMRN) Stock

Wall Street loves growth stocks — and for good reason. In 2018, according to Bank of America, “growth” oriented  mutual funds outperformed “value” …

Deciphera (DCPH) Stock at $62 a Share? Deutsche Bank Thinks It’s Possible

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Deciphera Pharmaceuticals …

This Latest Target Price On Foamix Looks Positively Frothy (In A Good Way)

Foamix Pharmaceuticals (FOMX) may be the best drug stock opportunity you’ve never heard of — and you should probably prepare yourself to hear …

Don’t Say Bye Bye to Amarin (AMRN) Stock, Say Buy Buy

One week ago, Stifel analyst Derek Archila reiterated his “buy” rating on anti-cholesterol drugmaker Amarin (AMRN). He did this partly because he liked …

Bank of America Sees Over 350% Upside in Foamix (FOMX) Stock

Foamix (FOMX) hasn’t had a great year, with shares falling 33% since the start of 2019. But things aren’t as bad as they …

Amarin (AMRN): Despite Reiterating “Buy” Rating, Stifel Tempers Expectations

In an acronym-heavy update, Stifel analyst Derek Archila reiterated his “buy” rating on anti-cholesterol  drugmaker Amarin Corporation (AMRN) following the company’s Q2 earnings …

Lannett Company (LCI) Stock Makes the Street Go Wild

Generic pharmaceutical products provider Lannett Company (LCI) is a puzzle. Lannett shares jumped as much as 50% today, before trimming back some gains …

Conatus (CNAT) Stock Price Could Hit Zero

Did an iceberg just wallop into Conatus (CNAT) stock? This biotech company’s shares plunged yesterday at breakneck speed of almost 70%.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts